Results

Total Results: 162 records

Showing results for "prostate cancer screening".
Users also searched for: psa

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/genitourinary-symptoms-protocol.pdf
    January 30, 2023 - ” in KQ1 as identifying underreported, symptom-based conditions (similar to screening for anxiety and … depression), rather than “screening” for an asymptomatic condition. … Does screening impact patient reported symptoms or improve quality of life? … rabbit or rabbits or rat or rats).ti,ab. 3287242 18 Penile Erection/ or Erectile Dysfunction/ or ProstaticNeoplasms/ or (erectile dysfunction or penile or prostate or prostatic).ti. 222326 19 or/16-18 8612157
  2. effectivehealthcare.ahrq.gov/products/health-equity-preventive/protocol
    August 31, 2018 - for breast cancer in African American women, prostate cancer in African American men, and illicit drug … exp Mass Screening/ screen*.ti,ab,kw. … exp Mass Screening/ or exp early diagnosis/ screen*.ti,ab,kw. … exp Mass Screening/ screen*.ti,ab,kw. … Mass Screening/ early diagnosis/ (screen* or test* or diagnosis).ti,ab,kw. 25 or 2 or/27-30
  3. effectivehealthcare.ahrq.gov/sites/default/files/pdf/health-equity-protocol.pdf
    January 01, 2020 - for breast cancer in African American women, prostate cancer in African American men, and illicit drug … Colorectal cancer screening Adults age 50 to 75 years Rates of screening based on screening modality … Breast cancer screening 4. Cervical cancer screening 5. Colorectal cancer screening 6. … High blood pressure in adults: screening 8. Lung cancer screening 9. … B-11 27 Mass Screening/ 28 early diagnosis/ 29 (screen* or test* or diagnosis).ti
  4. Organisation (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-radiation_appendixes.pdf
    June 16, 2008 - Experience with conformal proton therapy for early prostate cancer. … first clinical trial of proton beam therapy for prostate cancer in Japan. … Conformal proton therapy for early-stage prostate cancer. … Hypofractionated radiotherapy with carbon ion beams for prostate cancer. … Targeted alpha therapy of prostate cancer.
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/genitourinary-symptoms-protocol_0.pdf
    July 10, 2023 - depression), rather than “screening” for an asymptomatic condition. … Does screening impact patient reported symptoms or improve quality of life? … In general, the figure illustrates how screening or case-finding may identify patients with GSM, who … rabbit or rabbits or rat or rats).ti,ab. 3287242 18 Penile Erection/ or Erectile Dysfunction/ or ProstaticNeoplasms/ or (erectile dysfunction or penile or prostate or prostatic).ti. 222326 19 or/16-18 8612157
  6. effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-radiation-therapy-bone-metastases.pdf
    August 01, 2022 - Screening for psychological distress before radiotherapy for painful bone metastases may be useful to … Price Transparency and Variation for Prostate Cancer Radiation Therapy. The ASCO Post. … doi: https://ascopost.com/news/january-2020/price-transparency-and-variation-for-prostate- cancer-radiation-therapy … 10.21873/anticanres.12813 https://ascopost.com/news/january-2020/price-transparency-and-variation-for-prostate-cancer-radiation-therapy … / https://ascopost.com/news/january-2020/price-transparency-and-variation-for-prostate-cancer-radiation-therapy
  7. effectivehealthcare.ahrq.gov/health-topics/health-screening
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/presentations-future_research.pdf
    April 01, 2012 - For example, members of the stakeholder panel on treatment for localized prostate cancer 9 took into … 21 Enhancing Use and Quality of Colorectal Cancer Screening. … cancer. … cancer. … Future Research Needs for Comparative Effectiveness of Treatments for Localized Prostate Cancer.
  9. effectivehealthcare.ahrq.gov/products/health-literacy/research-protocol
    January 22, 2010 - "The role of numeracy on cancer screening among urban women." … "Screening tests for intended medication adherence among the elderly." … "Do prostate cancer patients want to choose their own radiation treatment?" … "Literacy, race, and PSA level among low-income men newly diagnosed with prostate cancer." … "Low-literacy interventions to promote discussion of prostate cancer: a randomized controlled trial."
  10. effectivehealthcare.ahrq.gov/sites/default/files/pdf/health-literacy_research-protocol.pdf
    January 22, 2010 - The role of numeracy on cancer screening among urban women. … Screening tests for intended medication adherence among the elderly. … Do prostate cancer patients want to choose their own radiation treatment? … Literacy, race, and PSA level among low-income men newly diagnosed with prostate cancer. … Low-literacy interventions to promote discussion of prostate cancer: a randomized controlled trial.
  11. effectivehealthcare.ahrq.gov/products/cancer-ovarian-contraceptives/research-protocol
    February 15, 2012 - If this is the case, screening, which is more likely to identify slower growing tumors, may have only … Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: … Screening for ovarian cancer: a pilot randomised controlled trial. … Screening for ovarian cancer. Vol. 2010. … Reducing ovarian cancer mortality through screening: Is it possible, and can we afford it?
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c-screening_disposition-comments.pdf
    November 27, 2012 - complications are as high as for some therapeutic or preventive procedures (e.g. radical prostatectomy for prostatecancer, colonoscopy with polypectomy for adenomatous polyps) and higher and more serious than for … of high -risk populations should not receive routine HCV screenings; however, none of the key questions … , many of the commonly administered immunizations, prostate cancer screening and so many others I cannot … Rather than explore screening vs. no screening, it would be more useful to compare different screening
  13. effectivehealthcare.ahrq.gov/sites/default/files/reporting.ppt
    September 01, 2009 - Methods: Eligibility Criteria (l) State the processes used to select studies for review: Screeningcancer detected by methods other than PSA [prostate-specific antigen] testing and treated with radical … prostatectomy experienced fewer deaths from prostate cancer, marginally fewer deaths from any cause, … Comparative Effectiveness of Therapies for Clinically Localized Prostate Cancer. … Comparative Effectiveness of Therapies for Clinically Localized Prostate Cancer.
  14. effectivehealthcare.ahrq.gov/health-topics/health-occupations
    January 17, 2012 - Review Archived February 1, 2013 PCA3 Testing in the Diagnosis and Management of ProstateCancer: Future Research Needs Systematic Review Archived April 1, 2013 Patient … Research Report November 9, 2009 Abstrackr: Software for Semi-Automatic Citation Screening
  15. effectivehealthcare.ahrq.gov/products/cancer-quality-indicator-testing/research
    May 19, 2010 - One included indicator (for pain screening) was split into 2 indicators (inpatient and outpatient). … Routine symptom screening and recording could improve capacity to evaluate outcomes. … necessary to identify eligible patients often not well documented IF a cancer patient has a positive screening … Pain If a cancer patient has a cancer-related outpatient visit then there should be screening for … using a numeric pain score IF a cancer patient is admitted to a hospital then there should be screening
  16. effectivehealthcare.ahrq.gov/products/weight-gain-prevention/research-protocol
    October 25, 2011 - This level of screening is liberal requiring only one reviewer indicating that a title is potentially … Abstract screening: Each abstract will be reviewed by 2 independent reviewers. … Weight gain is associated with an increased risk of prostate cancer recurrence after prostatectomy in … Effect of obesity on prostate-specific antigen recurrence after radiation therapy for localized prostatecancer as measured by the 2006 Radiation Therapy Oncology Group-American Society for Therapeutic Radiation
  17. effectivehealthcare.ahrq.gov/news/2020-year-in-review
    January 01, 2020 - Therapies for Clinically Localized Prostate Cancer . … Therapies for Clinically Localized Prostate Cancer: A Comparative Effectiveness Review . … cancer . … Documenting horizontal integration among urologists who treat prostate cancer . … Assessing the quality of surgical care for clinically localized prostate cancer: results from the CEASAR
  18. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-performance_methods.pdf
    July 01, 2012 - A clinically relevant example is the use of prostate-specific antigen (PSA) to detect prostate cancer … PSA levels have been used to detect the presence of prostate cancer, and over the years, a number of … However, PSA levels are not elevated in as many as 15 percent of individuals with prostate cancer, making … Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter … Comparison of a screening test and a reference test in epidemiologic studies. II.
  19. effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-options-summarizing.ppt
    June 01, 2012 - The prostate-specific antigen (PSA) test is used to detect prostate cancer. … cancer cases. … Prostate-specific antigen (PSA) levels have been used to detect prostate cancer. … Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter … Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-options-summarizing.ppt
    June 01, 2012 - The prostate-specific antigen (PSA) test is used to detect prostate cancer. … cancer cases. … Prostate-specific antigen (PSA) levels have been used to detect prostate cancer. … Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter … Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: